|
DE3812225A1
(de)
|
1988-04-13 |
1989-10-26 |
Basf Ag |
Isoxazol(isothiazol)-5-carbonsaeureamide
|
|
BR9606546A
(pt)
|
1995-08-02 |
1998-07-14 |
Uriach & Cia Sa J |
Novas carboxamidas com atividade fungicida
|
|
DE69628705T2
(de)
|
1995-08-24 |
2004-05-13 |
Basf Ag |
Isoxazole- und Isothiazole-5-carboxamid Derivate, deren Herstellung und deren Verwendung als Herbizide
|
|
EP0957099B1
(en)
|
1998-04-15 |
2002-11-20 |
Pfizer Products Inc. |
Heterocyclic carboxamides
|
|
AU2001273040A1
(en)
|
2000-06-27 |
2002-01-08 |
Du Pont Pharmaceuticals Company |
Factor xa inhibitors
|
|
CA2484209C
(en)
|
2002-05-03 |
2013-06-11 |
Exelixis, Inc. |
Protein kinase modulators and methods of use
|
|
ZA200603515B
(en)
|
2003-10-08 |
2007-11-28 |
Vertex Pharma |
Modulators of ATP-binding cassette transporters
|
|
RU2006120549A
(ru)
|
2003-11-14 |
2007-12-27 |
Вертекс Фармасьютикалз Инкорпорейтед (Us) |
Тиазолы и оксазолы, применяемые в качестве модуляторов транспортеров арт-связывающей кассеты
|
|
WO2005077345A1
(en)
|
2004-02-03 |
2005-08-25 |
Astrazeneca Ab |
Compounds for the treatment of gastro-esophageal reflux disease
|
|
WO2005077373A2
(en)
|
2004-02-03 |
2005-08-25 |
Astrazeneca Ab |
Treatment of gastro-esophageal reflux disease (gerd)
|
|
JP2008503446A
(ja)
|
2004-05-06 |
2008-02-07 |
プレキシコン，インコーポレーテッド |
Ｐｄｅ４ｂ阻害剤及びその使用
|
|
SE0401969D0
(sv)
|
2004-08-02 |
2004-08-02 |
Astrazeneca Ab |
Piperidine derivatives
|
|
WO2006031806A2
(en)
|
2004-09-10 |
2006-03-23 |
Atherogenics, Inc. |
2-thiopyrimidinones as therapeutic agents
|
|
DE102004051277A1
(de)
|
2004-10-21 |
2006-04-27 |
Merck Patent Gmbh |
Heterocyclische Carbonylverbindungen
|
|
JP2006176443A
(ja)
|
2004-12-22 |
2006-07-06 |
Shionogi & Co Ltd |
メラニン凝集ホルモン受容体アンタゴニスト
|
|
DE602006018301D1
(de)
|
2005-06-22 |
2010-12-30 |
Pfizer Prod Inc |
Histamin-3-rezeptorantagonisten
|
|
JP4822406B2
(ja)
|
2005-09-26 |
2011-11-24 |
ルネサスエレクトロニクス株式会社 |
表示制御駆動装置および表示システム
|
|
WO2007075896A2
(en)
|
2005-12-22 |
2007-07-05 |
Kemia, Inc. |
Heterocyclic cytokine inhibitors
|
|
KR101394245B1
(ko)
|
2005-12-30 |
2014-05-14 |
에스케이바이오팜 주식회사 |
아이속사졸 유도체 및 이의 용도
|
|
WO2007086584A1
(ja)
|
2006-01-30 |
2007-08-02 |
Meiji Seika Kaisha, Ltd. |
新規ＦａｂＫおよびＦａｂＩ／Ｋ阻害剤
|
|
TW200815351A
(en)
|
2006-05-02 |
2008-04-01 |
Astrazeneca Ab |
Novel compounds
|
|
US8193225B2
(en)
|
2006-10-13 |
2012-06-05 |
The Board Of Regents Of The University Of Texas System |
Isoxazole amides, derivatives and methods of chemical induction of neurogenesis
|
|
WO2008046072A2
(en)
|
2006-10-13 |
2008-04-17 |
The Board Of Regents Of The University Of Texas System |
Chemical inducers of neurogenesis
|
|
CN101528744A
(zh)
|
2006-10-20 |
2009-09-09 |
Irm责任有限公司 |
用于调节c-kit和pdgfr受体的组合物和方法
|
|
WO2008070739A1
(en)
|
2006-12-06 |
2008-06-12 |
Cytokinetics, Inc. |
Ksp activators
|
|
WO2009005269A2
(en)
|
2007-06-29 |
2009-01-08 |
Sk Holdings Co., Ltd. |
Pharmaceutical composition for preventintion and treatment of restenosis comprising isoxazole derivatives
|
|
US20090069288A1
(en)
|
2007-07-16 |
2009-03-12 |
Breinlinger Eric C |
Novel therapeutic compounds
|
|
CN101796036A
(zh)
|
2007-08-02 |
2010-08-04 |
欧加农股份有限公司 |
作为trpv1调节剂的5-苯基异噁唑-3-甲酰胺衍生物
|
|
US8642660B2
(en)
|
2007-12-21 |
2014-02-04 |
The University Of Rochester |
Method for altering the lifespan of eukaryotic organisms
|
|
US8236838B2
(en)
|
2008-04-21 |
2012-08-07 |
Institute For Oneworld Health |
Compounds, compositions and methods comprising isoxazole derivatives
|
|
US20090318429A1
(en)
|
2008-04-28 |
2009-12-24 |
Institute For Oneworld Health |
Compounds, Compositions and Methods Comprising Heteroaromatic Derivatives
|
|
AU2010211114A1
(en)
|
2009-02-04 |
2011-06-30 |
Msd Oss B.V. |
Isoxazole-5-carboxamide derivatives
|
|
KR101748891B1
(ko)
|
2009-03-11 |
2017-06-19 |
교린 세이야꾸 가부시키 가이샤 |
Ｇｓｋ-3 억제제로서의 7-시클로알킬아미노퀴놀론
|
|
KR101727762B1
(ko)
*
|
2009-03-20 |
2017-04-17 |
버텍스 파마슈티칼스 인코포레이티드 |
낭성 섬유증 막횡단 전도도 조절자의 조정자의 제조 방법
|
|
GB0910003D0
(en)
|
2009-06-11 |
2009-07-22 |
Univ Leuven Kath |
Novel compounds for the treatment of neurodegenerative diseases
|
|
IN2012DN00352A
(enExample)
|
2009-06-16 |
2015-08-21 |
Bikam Pharmaceuticals Inc |
|
|
WO2011008931A2
(en)
|
2009-07-15 |
2011-01-20 |
Cystic Fibrosis Foundation Therapeutics, Inc. |
Arylpyrimidine compounds and combination therapy comprising same for treating cystic fibrosis & related disorders
|
|
US9212177B2
(en)
|
2009-08-05 |
2015-12-15 |
Versitech Limited |
Antiviral compounds and methods of making and using thereof
|
|
GB2474120B
(en)
|
2009-10-01 |
2011-12-21 |
Amira Pharmaceuticals Inc |
Compounds as Lysophosphatidic acid receptor antagonists
|
|
US8569899B2
(en)
|
2009-12-30 |
2013-10-29 |
Stmicroelectronics, Inc. |
Device and method for alignment of vertically stacked wafers and die
|
|
US8247436B2
(en)
|
2010-03-19 |
2012-08-21 |
Novartis Ag |
Pyridine and pyrazine derivative for the treatment of CF
|
|
EP2560650A1
(en)
|
2010-04-22 |
2013-02-27 |
Vertex Pharmaceuticals Incorporated |
Pharmaceutical compositions and administrations thereof
|
|
BR112013000925A2
(pt)
|
2010-07-15 |
2020-12-01 |
Bayer Intellectual Property Gmbh |
compostos heterocíclicos como pesticidas
|
|
DK2684880T3
(en)
|
2011-03-10 |
2018-05-22 |
Daiichi Sankyo Co Ltd |
DISPIROPYRROLIDINE DERIVATIVES
|
|
CA2736441A1
(en)
|
2011-04-06 |
2012-10-06 |
The Regents Of The University Of California |
Pyrazolylthiazole compounds as .delta.f508-cystic fibrosis transmembrane conductance regulator correctors
|
|
DK3235812T3
(da)
*
|
2011-05-18 |
2019-11-25 |
Vertex Pharmaceuticals Europe Ltd |
Deutererede derivater af ivacaftor
|
|
HUE047354T2
(hu)
*
|
2011-05-18 |
2020-04-28 |
Vertex Pharmaceuticals Europe Ltd |
Ivacaftor deuterizált származékai
|
|
EP2736883B1
(en)
|
2011-07-29 |
2019-09-04 |
Karyopharm Therapeutics, Inc. |
Nuclear transport modulators and uses thereof
|
|
ES2882807T3
(es)
|
2011-09-16 |
2021-12-02 |
Novartis Ag |
Heterociclil carboxamidas N-sustituidas
|
|
WO2013038386A1
(en)
|
2011-09-16 |
2013-03-21 |
Novartis Ag |
Heterocyclic compounds for the treatment of cystic fibrosis
|
|
US8623860B2
(en)
|
2011-12-30 |
2014-01-07 |
Boehringer Ingelheim International Gmbh |
Azetidine derivatives, pharmaceutical compositions and uses thereof
|
|
BR102013003576B8
(pt)
|
2012-02-16 |
2022-10-11 |
Dow Agrosciences Llc |
Método para produzir n-ciano-s-metil-s-[1-(6-tri-flúormetil-3-piridinil)etil]sulfilimina
|
|
UA110436C2
(en)
|
2012-03-06 |
2015-12-25 |
Zoetis Llc |
Antibacterial phenol compounds
|
|
WO2013146970A1
(ja)
|
2012-03-29 |
2013-10-03 |
第一三共株式会社 |
新規キノリン誘導体
|
|
ES2869701T3
(es)
|
2012-08-01 |
2021-10-25 |
United Therapeutics Corp |
Tratamiento de hipertensión arterial pulmonar con células progenitoras endoteliales tratadas con prostaciclina
|
|
EP2898072A1
(en)
|
2012-09-24 |
2015-07-29 |
Yissum Research Development Company of the Hebrew University of Jerusalem Ltd. |
Restoration of the cftr function by splicing modulation
|
|
WO2014081820A1
(en)
|
2012-11-20 |
2014-05-30 |
Discoverybiomed, Inc. |
Small molecule cftr correctors
|
|
EP2922853A4
(en)
|
2012-11-20 |
2016-11-23 |
Discoverybiomed Inc |
SMALL MOLECULE BICYCLIC AND TRICYCLIC CFTR CORRECTING DEVICES
|
|
CN103833630B
(zh)
*
|
2012-11-21 |
2018-11-13 |
顶点制药（欧洲）有限公司 |
氘化cftr增效剂
|
|
US20140371238A1
(en)
|
2013-03-13 |
2014-12-18 |
Flatley Discovery Lab |
Compounds and methods for the treatment of cystic fibrosis
|
|
CN105307655B
(zh)
|
2013-03-13 |
2019-05-03 |
弗拉特利发现实验室有限责任公司 |
哒嗪酮化合物及其用于制备治疗囊肿状纤维化的药物的应用
|
|
MX372775B
(es)
|
2013-03-15 |
2020-06-29 |
Discoverybiomed Inc |
Derivados de cumarina y métodos de uso en el tratamiento de la fribosis quística, enfermedad pulmonar obstructiva crónica y trastornos de proteínas mal plegadas.
|
|
WO2014144860A1
(en)
|
2013-03-15 |
2014-09-18 |
Vertex Pharmaceuticals Incorporated |
Correctors acting through msd1 of cftr protein
|
|
US20160074374A1
(en)
|
2013-04-26 |
2016-03-17 |
Vertex Pharmaceuticals Incorporated |
Correctors acting through msd1 of cftr protein
|
|
MX368263B
(es)
|
2013-05-07 |
2019-09-26 |
Galapagos Nv |
Compuestos novedosos y composiciones farmaceuticas de los mismos para el tratamiento de fibrosis quistica.
|
|
WO2014181287A1
(en)
|
2013-05-09 |
2014-11-13 |
Piramal Enterprises Limited |
Heterocyclyl compounds and uses thereof
|
|
MX2015017532A
(es)
|
2013-06-26 |
2016-10-26 |
Proteostasis Therapeutics Inc |
Métodos para modular la actividad del regulador de transmembrana de fibrosis quística.
|
|
US9920073B2
(en)
|
2013-10-04 |
2018-03-20 |
Drexel University |
Compositions useful for inhibiting HIV-1 infection and methods using same
|
|
AU2015229188A1
(en)
|
2014-03-13 |
2016-09-29 |
Proteostasis Therapeutics, Inc. |
Compounds, compositions, and methods for increasing CFTR activity
|
|
CA2942387A1
(en)
|
2014-03-13 |
2015-09-17 |
Proteostasis Therapeutics, Inc. |
Compounds, compositions and methods of increasing cftr actvity
|
|
EP3157917B1
(en)
|
2014-06-19 |
2020-03-18 |
Proteostasis Therapeutics, Inc. |
Compounds, compositions and methods of increasing cftr activity
|
|
US9855249B2
(en)
|
2014-10-02 |
2018-01-02 |
Flatley Discovery Lab, Llc |
Isoxazole compounds and methods for the treatment of cystic fibrosis
|
|
WO2016105484A1
(en)
|
2014-12-23 |
2016-06-30 |
Proteostasis Therapeutics, Inc. |
Derivatives of 5-(hetero)arylpyrazol-3-carboxylic amide or 1-(hetero)aryltriazol-4-carboxylic amide useful for the treatment of inter alia cystic fibrosis
|
|
WO2016105468A1
(en)
|
2014-12-23 |
2016-06-30 |
Proteostasis Therapeutics, Inc. |
Derivatives of 3-heteroarylisoxazol-5-carboxylic amide useful for the treatment of inter alia cystic fibrosis
|
|
CA2971850A1
(en)
|
2014-12-23 |
2016-06-30 |
Proteostasis Therapeutics, Inc. |
Derivatives of 5-phenyl- or 5-heteroarylthiazol-2-carboxylic amide useful for the treatment of inter alia cystic fibrosis
|
|
MA41253A
(fr)
|
2014-12-23 |
2017-10-31 |
Proteostasis Therapeutics Inc |
Composés, compositions et procédés pour augmenter l'activité du cftr
|
|
US20180147187A1
(en)
|
2015-01-12 |
2018-05-31 |
Proteostasis Therapeutics, Inc. |
Compounds, compositions, and methods for increasing cftr activity
|
|
US10548878B2
(en)
|
2015-07-24 |
2020-02-04 |
Proteostasis Therapeutics, Inc. |
Compounds, compositions, and methods of increasing CFTR activity
|
|
WO2017040606A1
(en)
|
2015-08-31 |
2017-03-09 |
Proteostasis Therapeutics, Inc. |
Isoxazole derivatives for use in the treatment of pulmonary diseases and disorders
|
|
WO2017062581A1
(en)
|
2015-10-06 |
2017-04-13 |
Proteostasis Therapeutics, Inc. |
Compounds, compositions, and methods for modulating cftr
|
|
AU2016379388A1
(en)
|
2015-12-22 |
2018-07-12 |
Proteostasis Therapeutics, Inc. |
Methods of treating pulmonary diseases and disorders
|
|
US10662207B2
(en)
|
2016-04-07 |
2020-05-26 |
Proteostasis Therapeutics, Inc. |
Compounds, compositions, and methods for modulating CFTR
|
|
WO2017196843A1
(en)
|
2016-05-09 |
2017-11-16 |
Proteostasis Therapeutics, Inc. |
Methods of identifying cftr modulators
|
|
US10899751B2
(en)
|
2016-06-21 |
2021-01-26 |
Proteostasis Therapeutics, Inc. |
Compounds, compositions, and methods for increasing CFTR activity
|